During the past decade, Fondazione Epatocentro Ticino conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 3 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fondazione Epatocentro Ticino" #1 sponsor was "Fondazione Epatocentro Ticino" with 4 trials, followed by "AbbVie" with 1 trials sponsored, "Benedetta Terziroli, MD" with 1 trials sponsored, "Calliditas Therapeutics Suisse SA" with 1 trials sponsored and "Genfit" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fondazione Epatocentro Ticino" #1 collaborator was "Fondazione Epatocentro Ticino" with 2 trials as a collaborator, "Cantonal Hospital Chur" with 1 trials as a collaborator, "Cantonal Hospital of St. Gallen" with 1 trials as a collaborator, "Hospitales Universitarios Virgen del Rocío" with 1 trials as a collaborator and "Intercept Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Fondazione Epatocentro Ticino" are "Primary Biliary Cirrhosis" (2 trials), "Cholangitis, Sclerosing" (1 trials), "Chronic Hepatitis C Virus (HCV)" (1 trials), "Hepatitis C" (1 trials) and "Hepatitis, Autoimmune" (1 trials). Many other conditions were trialed in "Fondazione Epatocentro Ticino" in a lesser frequency.

Most popular intervention types in "Fondazione Epatocentro Ticino" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Control Test" (1 trials), "Elafibranor 80mg" (1 trials), "High-dose influenza vaccine" (1 trials) and "IVA337" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fondazione Epatocentro Ticino" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Fondazione Epatocentro Ticino". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Fondazione Epatocentro Ticino, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fondazione Epatocentro Ticino, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".